2 completed, 1 not yet recruiting, 1 recruiting. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Compulsive Personality Disorder: new trials by email Literature Review of Compulsive Personality Disorder trials Research Report on Compulsive Personality Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SONATA Dose Duration LIFU for OCD ATTN201 - Low Intensity Focused Ultrasound - Obsessive - Compulsive Disorder | Phase 2 | Recruiting | University of Pennsylvania | 20 | 2026-09-15 | 2026-10-21 |
| Psilocybin for Treatment of OCD-2 Low Dose Psilocybin, High Dose Psilocybin - Obsessive - Compulsive Disorder | Phase 1 / Phase 2 | Not yet recruiting | Francisco A Moreno | 20 | 2026-09-08 | 2026-05-12 |
| Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder riluzole, placebo - Obsessive-compulsive Disorder, Ocd | Phase 2 | Completed | Yale University | 40 | 2006-09-01 | 2020-03-06 |
| St. John's Wort Vs. Placebo in Obsessive-Compulsive Disorder. St. John's Wort - Obsessive Compulsive Disorder | Phase 2 | Completed | National Center for Complementary and Integrative Health (NCCIH) | 60 | 2002-05-01 | 2006-08-04 |
Obsessive-Compulsive Disorder (3) · Anxiety Disorders (1) · Psychological Well-Being (1)
Mental Disorders (4) · Personality Disorders (4) · Anxiety Disorders (2) · Behavior (1) · Personal Satisfaction (1)
Hypericum extract LI 160 (1) · Psilocybin (1) · Riluzole (1)
Francisco A Moreno (1) · National Center for Complementary and Integrative Health (NCCIH) (1) · University of Pennsylvania (1) · Yale University (1)
United States (4)
Christopher J Pittenger, MD, Ph.D. (1) · Francisco Moreno, MD (1) · Katherine Scangos, MD, PhD (1) · Kenneth Kobak, PhD (1) · Leslie Taylo, MD (1)
R34MH083115 (1)